Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMAX CORP Director's Dealing 2020

Jun 8, 2020

31800_dirs_2020-06-08_d41259fd-64bf-4f06-aa22-2323d67e24fe.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMAX CORP (IMAX)
CIK: 0000921582
Period of Report: 2020-06-04

Reporting Person: Demirian Eric A (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-06-04 common shares M 9765 $0.00 Acquired 50509 Direct
2020-06-04 common shares F 5228 $13.44 Disposed 45281 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-06-04 restricted share units $0.00 A 9765 Acquired common shares (9765) Direct
2020-06-04 restricted share units $0.00 M 9765 Disposed common shares (9765) Direct

Holdings (Non-Derivative)

Security Shares Ownership
common shares (opening balance) 40744 Direct

Footnotes

F1: Represents the conversion upon vesting of restricted share units into common shares.

F2: Mr. Demirian is reporting the withholding of common shares to satisfy the tax withholding obligations in connection with the delivery of common shares upon conversion of the restricted share unit.

F3: Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation.

F4: Each restricted share unit is the economic equivalent of one common share of IMAX Corporation.

F5: Mr. Demirian received a grant of restricted share units in connection with his membership on the IMAX Corporation Board of Directors.

F6: The restricted share units vest and convert to common shares on the date of grant, June 4, 2020.

F7: This represents Mr. Demirian's restricted share unit balance for this grant after this transaction. Mr. Demirian's total common share balance following this transaction will be 45,281.